Urovo Technology Co., Ltd. (SHE:300531)
China · Delayed Price · Currency is CNY 18.93
-0.43 (-2.22%)
Apr 30, 2026, 3:04 PM CST
Urovo Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,634 | 1,539 | 1,221 | 1,268 | 1,411 | 1,417 |
Other Revenue | - | - | 0.29 | 0.03 | 0.43 | 0.04 |
| 1,634 | 1,539 | 1,221 | 1,268 | 1,411 | 1,417 | |
Revenue Growth (YoY) | 30.09% | 26.05% | -3.67% | -10.18% | -0.37% | 22.19% |
Cost of Revenue | 1,214 | 1,141 | 957.83 | 939.72 | 1,044 | 1,023 |
Gross Profit | 420.41 | 398.65 | 263.36 | 328.02 | 367.27 | 393.98 |
Selling, General & Admin | 172.61 | 174.7 | 171.71 | 168 | 157.51 | 158.38 |
Research & Development | 134.41 | 136.32 | 117.72 | 104.81 | 93.92 | 85.25 |
Other Operating Expenses | -20.26 | -19.63 | -14.57 | -27.09 | -15.28 | -20.13 |
Operating Expenses | 286.76 | 291.39 | 281.94 | 258.68 | 239.74 | 227.35 |
Operating Income | 133.65 | 107.26 | -18.58 | 69.34 | 127.53 | 166.63 |
Interest Expense | - | - | -15.85 | -12.61 | -8.24 | -7.32 |
Interest & Investment Income | 0.91 | - | 23.63 | 27.06 | 35.32 | 11.8 |
Currency Exchange Gain (Loss) | - | - | 0.76 | 15.63 | 4.18 | -5.03 |
Other Non Operating Income (Expenses) | -10.19 | -5.53 | -2.75 | -2.25 | -4.59 | -2.53 |
EBT Excluding Unusual Items | 124.37 | 101.72 | -12.78 | 97.17 | 154.21 | 163.56 |
Impairment of Goodwill | - | - | -114.19 | -257.13 | -86.48 | - |
Gain (Loss) on Sale of Investments | -9.31 | -8.35 | -23.84 | -12.89 | 82.49 | -2.78 |
Gain (Loss) on Sale of Assets | 1.83 | 1.8 | 0.93 | 0 | 0.06 | 0 |
Asset Writedown | 2.58 | 2.16 | -0.18 | -0.15 | -0.33 | -0.04 |
Legal Settlements | - | - | -0.06 | - | -0.1 | -3.01 |
Other Unusual Items | - | - | 10.36 | 13.09 | 14.82 | 7.44 |
Pretax Income | 119.48 | 97.34 | -139.75 | -159.91 | 164.67 | 165.17 |
Income Tax Expense | 14.12 | 13.98 | 10.79 | 7.13 | 8.59 | 11.64 |
Earnings From Continuing Operations | 105.35 | 83.37 | -150.54 | -167.04 | 156.07 | 153.53 |
Minority Interest in Earnings | 0.07 | 0.05 | 0.08 | 0.21 | 0.29 | 0.14 |
Net Income | 105.42 | 83.42 | -150.47 | -166.84 | 156.36 | 153.67 |
Net Income to Common | 105.42 | 83.42 | -150.47 | -166.84 | 156.36 | 153.67 |
Net Income Growth | - | - | - | - | 1.75% | 28.94% |
Shares Outstanding (Basic) | 323 | 324 | 328 | 329 | 333 | 334 |
Shares Outstanding (Diluted) | 323 | 324 | 328 | 329 | 333 | 334 |
Shares Change (YoY) | -1.42% | -1.10% | -0.43% | -0.99% | -0.41% | 3.71% |
EPS (Basic) | 0.33 | 0.26 | -0.46 | -0.51 | 0.47 | 0.46 |
EPS (Diluted) | 0.33 | 0.26 | -0.46 | -0.51 | 0.47 | 0.46 |
EPS Growth | - | - | - | - | 2.17% | 24.32% |
Free Cash Flow | -259.58 | -100.38 | -42.62 | 194.93 | 56.51 | 124.46 |
Free Cash Flow Per Share | -0.81 | -0.31 | -0.13 | 0.59 | 0.17 | 0.37 |
Dividend Per Share | - | - | 0.050 | 0.050 | 0.050 | 0.051 |
Dividend Growth | - | - | - | - | -1.02% | 57.51% |
Gross Margin | 25.72% | 25.90% | 21.57% | 25.87% | 26.02% | 27.81% |
Operating Margin | 8.18% | 6.97% | -1.52% | 5.47% | 9.04% | 11.76% |
Profit Margin | 6.45% | 5.42% | -12.32% | -13.16% | 11.08% | 10.85% |
Free Cash Flow Margin | -15.88% | -6.52% | -3.49% | 15.38% | 4.00% | 8.79% |
EBITDA | 146.18 | 119.5 | -7.51 | 79.99 | 138.65 | 179.84 |
EBITDA Margin | 8.95% | 7.76% | -0.61% | 6.31% | 9.82% | 12.70% |
D&A For EBITDA | 12.53 | 12.24 | 11.07 | 10.65 | 11.11 | 13.21 |
EBIT | 133.65 | 107.26 | -18.58 | 69.34 | 127.53 | 166.63 |
EBIT Margin | 8.18% | 6.97% | -1.52% | 5.47% | 9.04% | 11.76% |
Effective Tax Rate | 11.82% | 14.36% | - | - | 5.22% | 7.05% |
Revenue as Reported | - | - | 1,221 | 1,268 | 1,411 | 1,417 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.